Inventor · disambiguated record
John J. Acton, Iii
Also filed as: ACTON III JOHN J · ACTON JOHN · ACTON JOHN J
17 granted patents·2 pending applications·239 citations·filing 1992–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0195US5719296APseudopeptide lactam inhibitors of peptide binding to MHC class II proteinsMERCK & CO INC·Filed 1996·Granted Feb 17, 1998·112 cites·9 claims
- 0289US6525083B2N-substituted indoles useful in the treatment of diabetesMERCK & CO INC·Filed 2001·Granted Feb 25, 2003·47 cites·37 claims
- 0386US6852738B2Acyl sulfamides for treatment of obesity, diabetes and lipid disordersMERCK & CO INC·Filed 2002·Granted Feb 8, 2005·32 cites·26 claims
- 0485US7345085B2Indoles having anti-diabetic activityMERCK & CO INC·Filed 2007·Granted Mar 18, 2008·8 cites·14 claims
- 0584US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 0681US9353101B2Cyclic amine substituted heterocyclic CETP inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 31, 2016·3 cites·17 claims
- 0780US7186746B2Indoles having anti-diabetic activityMERCK & CO INC·Filed 2003·Granted Mar 6, 2007·14 cites·54 claims
- 0878US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 0978US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1078US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 1173US7393960B2Indoles having anti-diabetic activityMERCK & CO INC·Filed 2003·Granted Jul 1, 2008·7 cites·17 claims
- 1264US2024228535A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1358US5506262ACholesterol lowering compoundsMERCK & CO INC·Filed 1992·Granted Apr 9, 1996·7 cites·9 claims
- 1449US11970479B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 30, 2024·0 cites·18 claims
- 1548US12319671B21-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 3, 2025·0 cites·16 claims
- 1646US11174248B2Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 16, 2021·0 cites·11 claims
- 1746US9650375B2Indole derivatives useful as anti-diabetic agentsMERCK SHARP & DOHME·Filed 2014·Granted May 16, 2017·0 cites·19 claims
- 1844US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 1943US2015274664A1Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentACTON JOHN J·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John J. Acton, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →